RECURRENT BURKITT LYMPHOMA
Clinical trials for RECURRENT BURKITT LYMPHOMA explained in plain language.
Never miss a new study
Get alerted when new RECURRENT BURKITT LYMPHOMA trials appear
Sign up with your email to follow new studies for RECURRENT BURKITT LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Six-Drug attack on tough blood cancers shows promise
Disease control Recruiting nowThis study is testing a combination of six chemotherapy drugs for people whose acute lymphoblastic leukemia (ALL) or lymphoblastic lymphoma has come back or hasn't responded to previous treatments. The goal is to see if this intensive combination is safe and can effectively contr…
Matched conditions: RECURRENT BURKITT LYMPHOMA
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC
-
Targeted drug combo offers hope for Tough-to-Treat leukemia
Disease control Recruiting nowThis study is testing a combination of a targeted cancer drug (inotuzumab ozogamicin), low-intensity chemotherapy, and an immunotherapy drug (blinatumomab) for adults with acute lymphoblastic leukemia (ALL). It focuses on older patients (60+) or younger patients who are too frail…
Matched conditions: RECURRENT BURKITT LYMPHOMA
Phase: PHASE1, PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Mar 30, 2026 14:29 UTC